SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-17-003384
Filing Date
2017-01-20
Accepted
2017-01-20 17:26:50
Documents
77
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A a16-22702_110qa.htm 10-Q/A 1669315
2 EX-31.1 a16-22702_1ex31d1.htm EX-31.1 12424
3 EX-31.2 a16-22702_1ex31d2.htm EX-31.2 12417
4 EX-32.1 a16-22702_1ex32d1.htm EX-32.1 7148
5 EX-32.2 a16-22702_1ex32d2.htm EX-32.2 7155
  Complete submission text file 0001104659-17-003384.txt   7960271

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT supn-20150930.xml EX-101.INS 2108550
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20150930.xsd EX-101.SCH 47872
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT supn-20150930_cal.xml EX-101.CAL 65454
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT supn-20150930_def.xml EX-101.DEF 157199
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT supn-20150930_lab.xml EX-101.LAB 449479
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20150930_pre.xml EX-101.PRE 333823
Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS INC (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q/A | Act: 34 | File No.: 001-35518 | Film No.: 17539335
SIC: 2834 Pharmaceutical Preparations